This is the authors' abstract. We don't add key points for this paper.
Statistically significant and clinically relevant improvements in functioning were seen in patients with MDD treated with vortioxetine in a real-world setting. Higher doses of vortioxetine were associated with significantly greater improvements in functioning.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Papalexi et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: